Pacific Biosciences of California Inc (PACB.OQ)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|69||2012||Chairman of the Board, President, Chief Executive Officer|
|64||2010||Chief Financial Officer, Executive Vice President|
|67||2017||Executive Vice President and Chief Commercial Officer and Director|
|67||2010||Senior Vice President - Research and Development|
|59||2010||Lead Independent Director|
- BRIEF-Pacific Biosciences Posts Favorable Outcome In UK And German Patent Litigation Against Oxford Nanopore
- BRIEF-Pacific Biosciences Of California Reports Qtrly Loss Per Share Of $0.20
- BRIEF-Pacific Biosciences Announces Ten-Unit Sequel System Order For Annoroad
- BRIEF-Pacific Biosciences Prevails In Patent Eligibility Ruling
- BRIEF-Pacific Biosciences Announces Issuance Of U.S. Patent For Concatemer Sequencing